Globus Medical, Inc.
GMED
$62.52
$2.023.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 745.34M | 598.12M | 657.29M | 625.71M | 629.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 745.34M | 598.12M | 657.29M | 625.71M | 629.69M |
| Cost of Revenue | 242.77M | 195.35M | 216.11M | 209.78M | 260.04M |
| Gross Profit | 502.58M | 402.77M | 441.18M | 415.93M | 369.65M |
| SG&A Expenses | 303.47M | 242.74M | 253.39M | 240.49M | 239.40M |
| Depreciation & Amortization | 30.19M | 28.80M | 29.91M | 30.08M | 29.71M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 616.17M | 499.86M | 532.76M | 515.15M | 566.82M |
| Operating Income | 129.17M | 98.26M | 124.53M | 110.55M | 62.87M |
| Income Before Tax | 188.17M | 103.67M | 24.67M | 57.03M | 47.58M |
| Income Tax Expenses | -14.67M | 28.21M | -1.84M | 5.20M | 15.82M |
| Earnings from Continuing Operations | 202.85M | 75.46M | 26.51M | 51.84M | 31.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 202.85M | 75.46M | 26.51M | 51.84M | 31.76M |
| EBIT | 129.17M | 98.26M | 124.53M | 110.55M | 62.87M |
| EBITDA | 199.85M | 164.40M | 192.76M | 177.50M | 126.67M |
| EPS Basic | 1.50 | 0.55 | 0.19 | 0.38 | 0.23 |
| Normalized Basic EPS | 0.60 | 0.48 | 0.40 | 0.55 | 0.28 |
| EPS Diluted | 1.49 | 0.54 | 0.19 | 0.38 | 0.23 |
| Normalized Diluted EPS | 0.60 | 0.47 | 0.40 | 0.54 | 0.28 |
| Average Basic Shares Outstanding | 135.21M | 136.76M | 136.73M | 135.62M | 135.20M |
| Average Diluted Shares Outstanding | 136.50M | 139.77M | 139.71M | 138.06M | 136.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |